Market Research Logo

CNS/Neurology Market Research Reports & Industry Analysis

Neurology and the CNS is the branch of science dealing with anatomy, function, diagnosis and treatment of disorders and disease affecting the central nervous system (brain and spinal cord). Neuroscience medicine includes but is not limited to the study and treatment of Alzheimer’s disease, major depressive disorder, schizophrenia, Parkinson’s disease, epilepsy/seizures, migraine, insomnia/sleep disorders, bipolar disorder, and ADHD.

A neurologist is a medical doctor that specializes in the diagnosis, treatment and management of illnesses affecting the brain, spinal cord, and nervous system. Neurologists must complete at least three years of specialized training in neurology, after completing medical school. A neurosurgeon must go through much more extensive and rigorous schooling and training. On top of diagnosing and treating neurological disorders, neurosurgeons can also perform surgery on the brain, spinal cord, and nerves.

Pharmaceuticals in CNS/Neurology are one of leading fields in medicine in terms of funding and research. On top of growing patient numbers, there remains a comparatively high unmet need in treatment of many neurological diseases. With the potential of being one of the most lucrative therapy areas in the future pharmaceutical Industry, Alzheimer's disease offers the greatest commercial opportunity for pharmaceutical companies in neurology. Many of the therapeutic drugs used to treat CNS/Neurological disorders have lost their patent protection or market exclusivity, leading to greater research and market opportunities for competing pharmaceutical and medical device companies. Despite the widespread use of CNS drugs, knowledge of these agents is limited due to the anatomic and neurochemical complexity of the brain and spinal cord.

...Show More ...Show Less


Filter your search

Research Assistance

Join Alert Me Now!

Sign Up

Find out more on our blog

CNS/Neurology Industry Research & Market Reports

  • Psychosis - Pipeline Review, H1 2016

    ...for Psychosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete ... Read More

  • Guillain-Barre Syndrome - Pipeline Review, H1 2016

    ...therapeutics under development for Guillain-Barre Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of ... Read More

  • Major Depressive Disorder - Pipeline Review, H1 2016

    ...information on the therapeutics under development for Major Depressive Disorder, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the ... Read More

  • Migraine Global Clinical Trials Review, H1, 2016

    ...to the clinical trials on Migraine. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country ... Read More

  • Mild Cognitive Impairment - Pipeline Review, H1 2016

    ...information on the therapeutics under development for Mild Cognitive Impairment, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the ... Read More

  • Subarachnoid Hemorrhage Global Clinical Trials Review, H1, 2016

    ...line data relating to the clinical trials on Subarachnoid Hemorrhage. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical ... Read More

  • Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016

    ...report provides comprehensive information on the therapeutics under development for Recurrent Glioblastoma Multiforme (GBM), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The ... Read More

  • Narcolepsy Global Clinical Trials Review, H1, 2016

    ...to the clinical trials on Narcolepsy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country ... Read More

  • Tinnitus Global Clinical Trials Review, H1, 2016

    ...to the clinical trials on Tinnitus. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country ... Read More

  • UK Amyotrophic Lateral Sclerosis Market and Competitive Landscape Highlights – 2016

    ...Sclerosis pipeline products, Amyotrophic Lateral Sclerosis epidemiology, Amyotrophic Lateral Sclerosis market valuations and forecast, Amyotrophic Lateral Sclerosis products sales and competitive landscape in UK. classified into nine sections – Amyotrophic Lateral Sclerosis overview including etiology, ... Read More

  • Germany Schizophrenia Market and Competitive Landscape Highlights – 2016

    ...market valuations and forecast, Schizophrenia products sales and competitive landscape in Germany. classified into nine sections – Schizophrenia overview including etiology, pathophysiology, and diagnosis, Schizophrenia treatment options, Schizophrenia pipeline products, Schizophrenia market analysis comprising of ... Read More

  • Italy Fibromyalgia Market and Competitive Landscape Highlights – 2016

    ...market valuations and forecast, Fibromyalgia products sales and competitive landscape in Italy. classified into nine sections – Fibromyalgia overview including etiology, pathophysiology, and diagnosis, Fibromyalgia treatment options, Fibromyalgia pipeline products, Fibromyalgia market analysis comprising of ... Read More

  • UK Cocaine Addiction Market and Competitive Landscape Highlights – 2016

    ...Cocaine Addiction epidemiology, Cocaine Addiction market valuations and forecast, Cocaine Addiction products sales and competitive landscape in UK. classified into nine sections – Cocaine Addiction overview including etiology, pathophysiology, and diagnosis, Cocaine Addiction treatment options, ... Read More

  • UK Glioblastoma Multiforme Market and Competitive Landscape Highlights – 2016

    ...Glioblastoma Multiforme epidemiology, Glioblastoma Multiforme market valuations and forecast, Glioblastoma Multiforme products sales and competitive landscape in UK. classified into nine sections – Glioblastoma Multiforme overview including etiology, pathophysiology, and diagnosis, Glioblastoma Multiforme treatment options, ... Read More

  • UK Opioid Addiction Market and Competitive Landscape Highlights – 2016

    ...Opioid Addiction epidemiology, Opioid Addiction market valuations and forecast, Opioid Addiction products sales and competitive landscape in UK. classified into nine sections – Opioid Addiction overview including etiology, pathophysiology, and diagnosis, Opioid Addiction treatment options, ... Read More

  • UK Schizophrenia Market and Competitive Landscape Highlights – 2016

    ...market valuations and forecast, Schizophrenia products sales and competitive landscape in UK. classified into nine sections – Schizophrenia overview including etiology, pathophysiology, and diagnosis, Schizophrenia treatment options, Schizophrenia pipeline products, Schizophrenia market analysis comprising of ... Read More

  • US Alcohol Dependence Market and Competitive Landscape Highlights – 2016

    ...Alcohol Dependence epidemiology, Alcohol Dependence market valuations and forecast, Alcohol Dependence products sales and competitive landscape in the US. classified into nine sections – Alcohol Dependence overview including etiology, pathophysiology, and diagnosis, Alcohol Dependence treatment ... Read More

  • Germany Brain Cancer Market and Competitive Landscape Highlights – 2016

    ...Brain Cancer epidemiology, Brain Cancer market valuations and forecast, Brain Cancer products sales and competitive landscape in Germany. classified into nine sections – Brain Cancer overview including etiology, pathophysiology, and diagnosis, Brain Cancer treatment options, ... Read More

  • US Autism Spectrum Disorder Market and Competitive Landscape Highlights – 2016

    ...Disorder pipeline products, Autism Spectrum Disorder epidemiology, Autism Spectrum Disorder market valuations and forecast, Autism Spectrum Disorder products sales and competitive landscape in the US. classified into nine sections – Autism Spectrum Disorder overview including ... Read More

  • US Depression Market and Competitive Landscape Highlights – 2016

    ...market valuations and forecast, Depression products sales and competitive landscape in the US. classified into nine sections – Depression overview including etiology, pathophysiology, and diagnosis, Depression treatment options, Depression pipeline products, Depression market analysis comprising ... Read More

  • Japan Bipolar Disorder Market and Competitive Landscape Highlights – 2016

    ...Bipolar Disorder epidemiology, Bipolar Disorder market valuations and forecast, Bipolar Disorder products sales and competitive landscape in Japan. classified into nine sections – Bipolar Disorder overview including etiology, pathophysiology, and diagnosis, Bipolar Disorder treatment options, ... Read More

  • Japan Cocaine Addiction Market and Competitive Landscape Highlights – 2016

    ...Cocaine Addiction epidemiology, Cocaine Addiction market valuations and forecast, Cocaine Addiction products sales and competitive landscape in Japan. classified into nine sections – Cocaine Addiction overview including etiology, pathophysiology, and diagnosis, Cocaine Addiction treatment options, ... Read More

  • Japan Fibromyalgia Market and Competitive Landscape Highlights – 2016

    ...market valuations and forecast, Fibromyalgia products sales and competitive landscape in Japan. classified into nine sections – Fibromyalgia overview including etiology, pathophysiology, and diagnosis, Fibromyalgia treatment options, Fibromyalgia pipeline products, Fibromyalgia market analysis comprising of ... Read More

  • Japan Glioblastoma Multiforme Market and Competitive Landscape Highlights – 2016

    ...Glioblastoma Multiforme epidemiology, Glioblastoma Multiforme market valuations and forecast, Glioblastoma Multiforme products sales and competitive landscape in Japan. classified into nine sections – Glioblastoma Multiforme overview including etiology, pathophysiology, and diagnosis, Glioblastoma Multiforme treatment options, ... Read More

  • Europe Depression Market and Competitive Landscape Highlights – 2016

    ...market valuations and forecast, Depression products sales and competitive landscape. The research focuses on key countries such as Germany, France, Italy, Spain, and UK. This report is classified into nine sections – Depression overview including ... Read More

3 4 5 6 8 10 11 12